The FDA has approved a first nanobody, lifting hopes for companies that are exploring innovative uses for domain antibodies. The FDA has approved a first nanobody, lifting hopes for companies… Click to show full abstract
The FDA has approved a first nanobody, lifting hopes for companies that are exploring innovative uses for domain antibodies. The FDA has approved a first nanobody, lifting hopes for companies that are exploring innovative uses for domain antibodies.
               
Click one of the above tabs to view related content.